F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
review of the medical record and interview with the staff the facility failed to ensure inventions were
attempted prior to the use of an as-needed antianxiety medication, and failed to ensure an as- needed
lorazepam was not administered more than 14 days without a stop date. This affected one resident
(Resident #22) of three residents revealed for behaviors. The facility census was 35.
Findings included:
1. Review of the medical record revealed Resident #22 was admitted to the facility on [DATE]. Diagnoses
included encephalopathy, end stage renal disease, altered mental status, congestive heart failure, chronic
obstructive pulmonary disease, atherosclerotic heart disease, hypertension, dependent on a ventilator,
tracheostomy, methicillin resistant staphylococcus aureus, intermittent explosive disorder, anxiety disorders,
gastrostomy, anoxic brain damage, foot drop, intracranial hemorrhage, and chronic metabolic acidosis.
Review of the significant change Minimum Data Set 3.0 assessment dated [DATE] revealed Resident # 22
had intact cognition and received an antipsychotic and antianxiety medications.
Review of the April 2024 physician's orders revealed Resident #22 had an order for lorazepam one
milligram (mg) intramuscularly (IM) every four hours as needed for anxiety and agitation dated 03/15/24.
Review of the March 2024 medication administration record revealed Resident #22 had lorazepam one
milligram without any non-pharmacological intervention attempted on 03/14/24 at 6:20 P.M., on 03/15/24 at
11:14 A.M., on 03/16/24 at 9:48 A.M., on 03/17/24 at 9:26 A.M., on 03/18/24 at 8:32 A.M., on 03/19/24 at
3:57 P.M., on 03/21/24 at 7:22 A.M. and 1:18 P.M., on 03/24/24 at 6:07 P.M., and on 03/25/24 at 4:35 A.M.
Review of the April 2024 medication administration record revealed Resident #22 had lorazepam one
milligram without any non-pharmacological intervention attempted on 04/01/24 at 11:38 P.M. on 4/02/24 at
4:04 A.M., on 04/08/24 at 9:39 A.M., on 04/09/24 at 12:38 A.M. and 12:27 P.M., on 04/15/23 at 7:22 P.M.
and on 04/16/24 at 6:10 A.M.
On 04/18/24 at 12:05 P.M. an interview with the Director of Nursing verified not all of his as-needed doses
of lorazepam administered to him had non-pharmacological intervention attempted prior to administration.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 2
Event ID:
365977
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
365977
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
04/23/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Circle of Care
1985 East Pershing Street
Salem, OH 44460
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Review of the undated facility policy titled, Psychotropic Drug, revealed the policy was to promote the
utilization of psychotropic drug in accordance with accepted principles of geriatric medicine and long-term
care practice.
2. Review of the medical record revealed Resident #22 was admitted to the facility on [DATE]. Diagnoses
included encephalopathy, end stage renal disease, altered mental status, congestive heart failure, chronic
obstructive pulmonary disease, atherosclerotic heart disease, hypertension, dependent on a ventilator,
tracheostomy, methicillin resistant staphylococcus aureus, intermittent explosive disorder, anxiety disorders,
gastrostomy, anoxic brain damage, foot drop, intracranial hemorrhage, and chronic metabolic acidosis.
Review of the significant change Minimum Data Set 3.0 assessment dated [DATE] revealed Resident # 22
had intact cognition and received an antipsychotic and antianxiety medications.
Review of the April 2024 physician's orders revealed Resident #22 had an order for lorazepam one
milligram IM every four hours as needed for anxiety and agitation dated 03/15/24. There was no stop date
for the as-needed psychotropic medications.
On 04/18/24 at 12:05 P.M. an interview with the Director of Nursing verified they did not have a stop date for
the lorazepam one milligram IM for Resident #22.
Review of the undated facility policy titled, Psychotropic Drug, revealed the policy was to promote the
utilization of psychotropic drug in accordance with accepted principles of geriatric medicine and long-term
care practice.
This deficiency represents non-compliance investigated under Complaint Number OH00151543.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
365977
If continuation sheet
Page 2 of 2